Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm Elpiscience

Login to View

Chinese biotech company Elpiscience Biopharmaceuticals Co. has completed a US$35 million series A+ round of financing led by Hillhouse Capital, with participation from CDH Investments and Lilly Asia Ventures (LAV).

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now


Already have an account or paid subscription? Log in


RELATED NEWS